FEATURED, Genetics, News, BRCA, Genetic Testing
DIRECT TO CONSUMER GENE TESTING MAY BE A GAME CHANGER
What are your plans for patients who arrive with their genetic profiles? On March 16, 2018, the United States Food and Drug Administration (FDA) authorized 23an...
FEATURED, Neoadjuvant Treatment, News, BRCA, PARP Inhibitors
Neoadjuvant Single-Agent PARP Inhibitor Appears Promising in BRCA Patients
BRCA patients may be able to take only one pill a day in a neoadjuvant setting The results of a small phase II trial suggest that the PARP inhibitor, talazopari...
